Equities

Premier Inc

PINC:NSQ

Premier Inc

Actions
Health CareHealth Care Providers
  • Price (USD)20.35
  • Today's Change-0.13 / -0.63%
  • Shares traded1.22m
  • 1 Year change-7.54%
  • Beta0.4034
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Premier Inc's net income fell -31.70% from 175.03m to 119.54m despite flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 32.92% to 34.04%.
Gross margin65.96%
Net profit margin7.93%
Operating margin9.51%
Return on assets3.15%
Return on equity5.56%
Return on investment4.10%
More ▼

Cash flow in USDView more

In 2024, Premier Inc increased its cash reserves by 39.37%, or 35.35m. The company earned 296.56m from its operations for a Cash Flow Margin of 22.03%. In addition the company used 68.47m on investing activities and also paid 192.72m in financing cash flows.
Cash flow per share2.06
Price/Cash flow per share8.65
Book value per share18.68
Tangible book value per share6.64
More ▼

Balance sheet in USDView more

Premier Inc has a Debt to Total Capital ratio of 27.75%, a higher figure than the previous year's 4.38%.
Current ratio1.00
Quick ratio0.8951
Total debt/total equity0.3841
Total debt/total capital0.2775
More ▼

Growth rates in USD

Year on year, growth in dividends per share increased 1.20% while earnings per share excluding extraordinary items fell by -28.43%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)2.27%
Div growth rate (5 year)--
Payout ratio (TTM)80.48%
EPS growth(5 years)-22.80
EPS (TTM) vs
TTM 1 year ago
-28.96
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.